174 related articles for article (PubMed ID: 26622885)
1. Percutaneous biliary stenting combined with radiotherapy as a treatment for unresectable hilar cholangiocarcinoma.
Tan Y; Zhu JY; Qiu BA; Xia NX; Wang JH
Oncol Lett; 2015 Oct; 10(4):2537-2542. PubMed ID: 26622885
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
3. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma.
Shinchi H; Takao S; Nishida H; Aikou T
J Surg Oncol; 2000 Oct; 75(2):89-94. PubMed ID: 11064386
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma.
Zheng WH; Yu T; Luo YH; Wang Y; Liu YF; Hua XD; Lin J; Ma ZH; Ai FL; Wang TL
World J Gastrointest Oncol; 2019 Jun; 11(6):489-498. PubMed ID: 31236199
[TBL] [Abstract][Full Text] [Related]
5. Palliative treatment with radiation-emitting metallic stents in unresectable Bismuth type III or IV hilar cholangiocarcinoma.
Lu J; Guo JH; Zhu HD; Zhu GY; Wang Y; Zhang Q; Chen L; Wang C; Pan TF; Teng GJ
ESMO Open; 2017; 2(4):e000242. PubMed ID: 29018577
[TBL] [Abstract][Full Text] [Related]
6. Y-shaped endoscopic bilateral metal stent placement for malignant hilar biliary obstruction: prospective long-term study.
Hwang JC; Kim JH; Lim SG; Kim SS; Yoo BM; Cho SW
Scand J Gastroenterol; 2011 Mar; 46(3):326-32. PubMed ID: 21082874
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous biliary approach as a successful rescue procedure after failed endoscopic therapy for drainage in advanced hilar tumors.
Jang SI; Hwang JH; Lee KH; Yu JS; Kim HW; Yoon CJ; Lee YS; Paik KH; Lee SH; Lee DK
J Gastroenterol Hepatol; 2017 Apr; 32(4):932-938. PubMed ID: 27665310
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.
Lee TY; Cheon YK; Shim CS; Cho YD
World J Gastroenterol; 2012 Oct; 18(39):5589-94. PubMed ID: 23112552
[TBL] [Abstract][Full Text] [Related]
9. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous insertion of a novel dedicated metal stent to treat malignant hilar biliary obstruction.
Cortese F; Acquafredda F; Mardighian A; Zurlo MT; Ferraro V; Memeo R; Spiliopoulos S; Inchingolo R
World J Gastrointest Oncol; 2022 Sep; 14(9):1833-1843. PubMed ID: 36187389
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial.
Yang J; Wang J; Zhou H; Zhou Y; Wang Y; Jin H; Lou Q; Zhang X
Endoscopy; 2018 Aug; 50(8):751-760. PubMed ID: 29342492
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous Metallic Stent Placement for Palliative Management of Malignant Biliary Hilar Obstruction.
Shim DJ; Gwon DI; Han K; Kim Y; Ko GY; Shin JH; Ko HK; Kim JH; Kim JW; Yoon HK; Sung KB
Korean J Radiol; 2018; 19(4):597-605. PubMed ID: 29962866
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of slimmer and open-cell-design stents for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video).
Kim JY; Kang DH; Kim HW; Choi CW; Kim ID; Hwang JH; Kim DU; Eum JS; Bae YM
Gastrointest Endosc; 2009 Dec; 70(6):1109-15. PubMed ID: 19647244
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma.
Wang Y; Cui W; Fan W; Zhang Y; Yao W; Huang K; Li J
Oncotarget; 2016 Aug; 7(33):53911-53920. PubMed ID: 27322076
[TBL] [Abstract][Full Text] [Related]
15. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
16. Stage of hilar cholangiocarcinoma predicts recurrence of biliary obstruction in patients with metal stents.
Siddiqui A; Shahid H; Sarkar A; Cox K; Kowalski TE; Loren DE; Sharma A; Laing P; Birch M; Adler DG
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1169-73. PubMed ID: 23811239
[TBL] [Abstract][Full Text] [Related]
17. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction.
Naitoh I; Ohara H; Nakazawa T; Ando T; Hayashi K; Okumura F; Okayama Y; Sano H; Kitajima Y; Hirai M; Ban T; Miyabe K; Ueno K; Yamashita H; Joh T
J Gastroenterol Hepatol; 2009 Apr; 24(4):552-7. PubMed ID: 19220678
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.
Singh V; Kapoor R; Solanki KK; Singh G; Verma GR; Sharma SC
Liver Int; 2007 Apr; 27(3):347-52. PubMed ID: 17355456
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review.
Rebhun J; Shin CM; Siddiqui UD; Villa E
World J Gastrointest Endosc; 2023 Mar; 15(3):177-190. PubMed ID: 37034966
[TBL] [Abstract][Full Text] [Related]
20. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.
Freeman ML; Overby C
Gastrointest Endosc; 2003 Jul; 58(1):41-9. PubMed ID: 12838219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
